Lance Berkman struggled for the Yankees after coming over in a July 31 trade and finished the season with an OPS below .800 for the first time in his career, but it sounds like the 34-year-old first baseman is getting plenty of interest as a free agent.
Ken Rosenthal of FOXSports.com calls the A’s “his most fervent suitor” and Carrie Muskat of MLB.com writes that “the Cubs are in pursuit of a first baseman this offseason and one option could be Berkman.”
Berkman has said previously that he’d like to remain a first baseman, but Daric Barton’s presence means he’d been primarily a designated hitter in Oakland. With the Cubs he could play first base and return to the National League, but it’s unclear exactly how interested they are in Berkman.
Even in a career-worst season Berkman got on base at a strong .368 clip and if his power returns somewhat a year removed from knee surgery he could be a nice one-year pickup.
The Athletic’s Ken Rosenthal and Zach Buchanan report that the Diamondbacks are one of several teams that have used labs other than the Sports Medicine Research and Testing Laboratory in Utah to process COVID-19 testing. MLB has encountered delays with its testing, despite promising 24-hour turnaround time, so teams have tried other avenues — with the league’s endorsement — in order to get faster results.
The SMRTL had processed performance-enhancing drug screenings for MLB. The league converted it to process COVID-19 tests amid concerns that having a season and all of the testing that would be required throughout would take away testing resources from the general public. That some teams are utilizing labs other than the SMRTL suggests the league, indeed, is usurping those resources.
In prospect Seth Beer’s case, he tested positive for COVID-19. He needed to test negative twice consecutively to be cleared to return to play. Beer went to a third-party site in the Phoenix area. He received his second negative test and was cleared to return on July 9.
The Diamondbacks said that the labs they have used have assured them that they are not taking away tests from the public. That seems like a claim MLB and the D-Backs should demonstrably prove. Per Rosenthal and Buchahan, the D-Backs have gone to an outside lab about 20 times, which accounts for less than one percent of COVID-19 tests taken by players and staff. Still, those are 20 tests that could have been used by the general public. And if the D-Backs and a handful of other teams already are using outside labs, then the rest of the league likely already is or soon will be doing the same. In the end, there will be a lot more than 20 tests taken at outside labs by MLB players and staff. Considering that “Tier 1” players will be tested every other day throughout the season, the total of third-party tests taken — if things continue the way they are now — could easily reach into the thousands by the end of October.
We all want baseball back, but the players, coaches, and all other staff are no more important than cashiers, teachers, and delivery drivers, so they shouldn’t have more access to COVID-19 testing simply by virtue of being associated with Major League Baseball and all of its influence and financial muscle. It would be unethical for MLB to be cutting in line ahead of other people who need testing just as much as if not more than the players.